Supreme Petrochem Ltd. Overview
Supreme Petrochem is India's dominant producer of styrenic polymers, with more than 50% domestic share in polystyrene (PS) and expandable polystyrene (EPS). It operates the country's only extruded polystyrene (XPS) insulation-board plant and, since September 2025, India's first continuous mass-ABS line (70,000 TPA, licensed from Versalis/Eni). The company is a joint venture of two Mumbai business families: the Taparias (The Supreme Industries, India's largest plastics processor) and the Rajan Raheja group. It converts imported styrene monomer into PS, EPS, ABS, compounds, masterbatches and XPS at a single integrated complex at Amdoshi (Raigad, Maharashtra) and an EPS plant in Chennai. It also trades styrene monomer, which supplied about 20% of FY26 turnover. Earnings follow the styrene–polymer spread cycle. The balance sheet has no borrowings, ₹874 cr of investable surplus (June 2026) and a 60% payout policy in practice. The strategy is to move the mix from commodity PS/EPS toward engineering plastics (ABS, compounds) and building insulation while defending scale leadership against imports.
What the company does. SPL is a downstream petrochemical manufacturer in the styrenics value chain. It does not produce styrene monomer (SM) itself, which is in structural deficit in India. Instead it imports SM, mainly from the Middle East, Singapore and East Asia, and polymerises it into:
-
general-purpose and high-impact polystyrene (GPPS, HIPS);
-
expandable polystyrene beads (EPS, sold to moulders who make "thermocol");
-
mass acrylonitrile-butadiene-styrene (ABS);
-
specialty polymer compounds (SPC) and masterbatches based on styrenics, PP and nylon;
-
XPS rigid insulation boards.
It also resells imported SM to domestic users, a lower-margin trading activity.
The company's own description. In its FY26 BRSR and investor decks, SPL describes itself as primarily a B2B supplier serving original equipment manufacturers (OEMs) and a broad range of manufacturers. Named end uses include:
-
air-conditioner, refrigerator and washing-machine OEMs;
-
air-cooler and geyser housings, household goods, cutlery, dairy packaging, TV and computer parts, stationery and imitation jewellery;
-
protective packaging for electricals;
-
fisheries, produce and pharmaceutical packaging;
-
blocks and sheets for false ceilings.
The investor deck calls the Amdoshi site "India's first truly international scale state-of-art Styrenics complex" and claims market leadership in PS and EPS with a share above 50%.
Revenue model. SPL earns essentially all of its revenue from product sales. It has no subscription, licensing or service income.
Pricing is not publicly disclosed product by product. Commentary from management and CRISIL shows that polymer prices track international SM and polymer benchmarks, so profitability is driven by the "delta" (spread) between SM and finished polymer rather than by absolute price. The Q1 FY27 call cited GPPS deltas widening by about US$200/t and HIPS by US$300–400/t. Raw-material inventory of 30–40 days, plus 4–6 weeks of material in transit (CRISIL), creates inventory gains when prices rise and losses when they fall.
Value-chain position. The chain runs: crude/naphtha → benzene + ethylene → styrene monomer (imported) → SPL polymerisation → converters and moulders (injection moulding, thermoforming, EPS moulding, compounding) → OEMs and end markets. Promoter Supreme Industries is itself a downstream converter, and related-party sales were 2.42% of SPL's sales in FY26 (BRSR).
Customer types and channels.
-
Sales are mostly direct.
-
Dealers and distributors handled 11% of sales in FY26 (8% in FY25), through 14 distributors; the top 10 accounted for 98% of distributor sales (BRSR).
-
The customer base is split between OEMs and non-OEM processors (CRISIL). The non-OEM segment is the more price-elastic: it cut purchases sharply when SM prices spiked in Q1 FY27.
-
Customers are in about 100 countries.
-
SPL holds Three Star Export House status, valid to 31 March 2028.
End markets served.
Independent characterisation. SPL is a spread-driven, import-substituting converter with near-monopoly domestic scale in PS. That status was reinforced in FY2021 when the second-largest producer's plant (LG Polymers, Visakhapatnam) shut after the May 2020 styrene leak. CRISIL notes that the second-largest player's plant closed in FY2021. SPL's moat rests on four things: scale; logistics proximity to West-India appliance clusters; a long-standing grade portfolio designed to counter low-priced imports; and conservative finances. Its weaknesses are total dependence on imported SM, heavy exposure to the Indian cooling-appliance cycle, and a historically thin specialty mix (SPC and XPS were about 6% of FY25 revenue, per CRISIL). The ABS, compounding (Xmold) and XPS expansions are the first credible move up the value curve, but execution in FY26 was uneven: ABS started six months late and then halted for an equipment failure.
Strategy
Stated strategic themes (Annual Report FY26, investor decks, earnings calls; paraphrased).
-
Defend leadership in PS and EPS through scale, quality and grades designed against imports. Market share is above 50%.
-
Diversify into higher-value engineering plastics (mass ABS, ABS-based compounds) to lift the through-cycle margin and reduce PS cyclicality.
-
Grow value-added downstream: specialty compounds, masterbatches and XPS insulation, aimed at OEM, auto and building-energy-efficiency demand.
-
Expand geographically within India: South (Xmold, Manali) and North (Karnal greenfield).
-
Remain debt-free and fund all capex from internal accruals and liquid surplus.
-
Pursue sustainability: about 50% renewable power, zero liquid discharge at both plants, post-consumer EPS/PS recycling with ICPE and NGOs, and EPR compliance.
Initiatives in the last 24 months.
Medium-term financial targets and guidance.
FY26 (given early FY26): about 10% volume growth, made up of 3–4% from the base business and 6–7% from ABS. Actual growth was 2%.
FY27: an earlier 8–10% volume growth figure was conditional on market normalcy by end-June 2026. On the Q1 FY27 call (July 2026), management declined to give volume or margin guidance because of West Asia uncertainty and called the Q1 margin of about 19% an aberration.
CRISIL base case: 4–6% annual volume growth in the base business, a steady-state operating margin of about 7%, and liquid surplus of ₹400–500 cr.
India Ratings: the outlook depends on reaching sustained EBITDA of INR 5.5–6.0 bn.
- No formal ROE or margin targets are published by the company.
Products & Services
All products are sold B2B. Specific grade names and price lists are not publicly disclosed. Pricing follows market (spot or formula) terms linked to SM and international polymer benchmarks.
General Purpose Polystyrene (GPPS)
Description: Transparent amorphous styrene homopolymer for injection moulding and extrusion.
Key properties: High clarity and gloss, good dimensional stability, easy processing, FDA-compliant grades (Q1 FY27 deck). SPL follows EU 10/2011 and US FDA 21 CFR 176.17 food-contact standards (BRSR).
Target customers: Refrigerator-component moulders, stationery and writing-instrument makers, rigid-sheet extruders, medical-disposable and household-goods producers, bead and bangle makers.
Launch: Since 1995. Capacity is shared with HIPS (300,000 TPA).
Flagship role: Core volume product. India imported about 87,000 t of PS in FY26 (Q1 FY27 call), the main competing supply.
High Impact Polystyrene (HIPS)
Description: Rubber-modified, opaque PS with high impact strength and stiffness.
Properties: Wide processing window, balanced mechanicals, high flexural strength.
Target customers: Refrigerator cabinet and liner makers, AC and cooler body moulders, toy makers, computer-accessory producers, food and dairy packaging thermoformers.
Launch: Since 1995.
Note: HIPS deltas widened most sharply in Q1 FY27 (+US$300–400/t).
Expandable Polystyrene (EPS)
Description: PS beads impregnated with pentane that expand and fuse into foam ("thermocol").
Properties: Light weight, thermal insulation, cushioning, mouldable into any shape.
Target customers: Consumer-durable packaging moulders; fish and fruit packaging; cold-storage and building-insulation panel makers; helmet and infant car-seat producers; 3D construction panels; geofoam for road building.
Capacity: Amdoshi plus Manali (Chennai), about 33,000 TPA at Manali. EPS Phase II was completed in 2026, taking stated installed capacity to 143,000 TPA.
Launch: EPS since the 2000s (Amdoshi). The Chennai brownfield expansion was commissioned around November 2022.
Competitive note: New domestic EPS capacity, including Styrenix and EPACK per KRChoksey (FY25), intensifies competition.
Mass ABS (Acrylonitrile Butadiene Styrene)
Description: Opaque engineering thermoplastic made by continuous mass polymerisation. SPL describes this as a first in India. The technology is licensed from Versalis S.p.A., Italy (imported 2022, first line fully absorbed per AR FY26).
Claimed attributes versus emulsion ABS: Better lot-to-lot consistency, lower base colour and more efficient colouring, better UV and thermal stability, fewer gels, lower VOCs, higher melt strength. Customer benefits claimed include less scrap, lower pigment use, lower regrind, better surface finish, lower odour (vehicle interiors) and better thermoforming. The process is also cleaner, with no water-pollution stream from emulsion polymerisation.
Applications: Automotive sheet and components, e-scooters, small electrical devices, mixers and grinders, RO purifiers, coolers, refrigerators, toys, helmets, clocks, auto batteries, medical equipment and bathroom fittings.
Capacity: 70,000 TPA, commissioned 25 September 2025. Terminal nameplate after Phase II is 140,000 TPA. Total project cost for both phases is estimated at about ₹850 cr (PolymerUpdate).
Status: Halted in December 2025 for an equipment failure and restarted in February–March 2026. Management targets about 36,000 t of ABS volume in FY27, roughly 65% utilisation (pre-Q1 FY27 benchmark). No advance order book was taken; OEM approvals for ABS compounds began after sample matching (Q3 FY26 call).
Specialty Polymer Compounds (SPC)
Description: Ready-to-use custom grades with functional minerals and additives, formulated in GPPS, HIPS, SAN, ABS, PP and nylon.
Property families: - flame-retardant (electrical switch accessories, auto and industrial batteries);
-
UV-stabilised custom-colour (ACs, washing machines, TVs, water heaters, purifiers, kitchen appliances);
-
mineral- and glass-filled (auto exterior, interior and under-hood parts, blower and fan impellers, textile bobbins);
-
impact-modified, low-shrink, high-heat.
Target customers: Appliance and auto OEMs and their Tier-I/II moulders.
Capacity: Masterbatches and compounds 50,000 TPA at Amdoshi, expanding to 80,000 TPA (ABS compounding focus), plus Xmold's 15,000 TPA in Tamil Nadu.
Strategic role: Captive outlet for ABS. Xmold gives direct access to southern auto and appliance clusters (Chennai, Sri City) and laboratory capability.
Masterbatches
Description: Concentrates of colourants, specialty minerals and performance additives.
Functions: Lower material and energy cost; better colour, brightness and surface finish; resistance to UV and heat, blocking, static, fire and microbial fouling.
Product families: - White and additive masterbatches: dairy, edible oil and ghee, grain, cereal and juice packaging, medical, cosmetics, fertiliser and pesticide packaging.
-
Black masterbatches: pipes and films for agriculture and irrigation.
-
Colour masterbatches: appliances, auto parts, switch accessories, kitchenware, toys, stationery, geotextiles.
Extruded Polystyrene (XPS) insulation board — "INSUboard"
Description: Rigid closed-cell foam board made by fully automated continuous extrusion. SPL operates India's first and only XPS plant (company claim).
Properties: High compressive strength, high R-value, low water absorption.
Applications: Wall, roof and floor insulation for commercial and residential buildings; refrigerated vehicles; vaccine and medicine boxes; tunnel linings.
Capacity: 72,000 m³, expanding to 122,000 m³.
Strategic angle: Energy-efficiency building codes and cold chain.
Styrene Monomer (traded)
Description: Imported SM resold to domestic users. India is in SM deficit.
Scale: 19.76% of FY26 turnover (BRSR).
Margin profile: Low margin; dilutes blended margins (KRChoksey).
Other listed specialties
- Exchange and aggregator profiles also list Styrene Methyl Methacrylate (SMMA) among SPL's products. No separate capacity or revenue is disclosed in the FY26 presentation.
Services
- Technical support only: processing guidelines and troubleshooting guides for customers, and customer-satisfaction surveys every two years (BRSR). No standalone service revenue.
Financial Narrative
All figures are standalone, INR Mn, for fiscal years ending 31 March. Sources: AR FY26 ten-year Performance Highlights (lakh converted to Mn), the Q2 FY26 and Q1 FY27 presentations, and Stock Analysis/Stockopedia for cash flows and gross profit where the company is silent.
Income statement
Notes:
-
FY22 operating EBITDA is derived (total EBITDA minus other income).
-
Gross profit is the Stock Analysis computation (revenue minus cost of revenue on its revenue base). SPL does not report gross profit under Ind AS.
-
The FY26 exceptional item of INR 100 Mn includes INR 29 Mn booked in Q4. Its nature is not detailed in sources reviewed.
-
EPS for FY22 is on the post-split FV ₹2 basis (AR footnote).
-
FY22 and FY23 reported DPS include pre-split interim and final dividends on ₹4 shares (FY22: ₹4 interim + ₹14 final; FY23: ₹4 pre-split interim + ₹7 final). These are adjusted ÷2 for the pre-split components.
-
Consolidated FY26: total income INR 54,498 Mn, revenue from operations INR 54,063 Mn, PBT INR 4,481 Mn, PAT INR 3,299 Mn (AR FY26 Board's Report). Xmold therefore added roughly INR 680 Mn of revenue and about INR 26 Mn of PAT before eliminations (derived).
Margins and growth
Revenue CAGR.
-
FY2022–FY2026 (4 years): 1.5% per year (derived).
-
FY2021–FY2026 (5 years, from FY21 net sales of INR 31,852 Mn): 10.9% per year (derived).
Commentary.
FY22 was the cycle peak: Pandemic-era supply tightness and wide SM–PS deltas lifted the operating EBITDA margin to about 18% and ROANW to 51%. CRISIL confirms margins of 18–21% in FY21–FY22, against 3–10% before FY2020.
FY23–FY24 normalised: Revenue was flat at about INR 52.5–52.9 bn despite 13.7% volume growth in FY24, because SM fell more than 11% in FY24 (AR FY24). Margins compressed to below 9%.
FY25 was a volume year: Revenue rose 14.7% on higher prices and 9.4% volume growth. Margins held at 8.8%, but depreciation and finance costs (leases) rose as new capacity was capitalised.
FY26 was a trough with a sharp exit: Revenue fell 11.4% because average SM prices dropped about 17% while volume grew only 2%. Causes were unseasonal rains, a mild summer hitting AC and refrigerator demand, deferred purchases ahead of GST rate cuts on durables, tariff-driven trade-flow shifts, rising imports and destocking (AR FY26; Q2 FY26 deck).
The quarterly path was a V: Q3 bottomed at a 5.5% operating margin with ABS halted and SM falling. Q4 recovered to 16.0% as the West Asia war widened international deltas.
D&A rose 34% in FY26: as ABS and expansions were capitalised; the gross block roughly doubled (PPE from INR 6.9 bn to INR 13.6 bn).
Q1 FY27 was a record at the EBITDA level: Revenue was INR 16,927 Mn (+22% YoY) on 24.5% lower volume. Operating EBITDA was INR 3,305 Mn (19.53% margin) and PAT INR 2,363 Mn (+192%). Management itself calls the margin an "aberration" driven by global deltas rather than structural improvement.
Balance sheet — five-year summary
FY22–FY23 total assets are derived as net worth × (1 + TOL/NW). On "Borrowings", AR FY26 confirms no term loan was availed or used as at 31 March 2026, and the company describes itself as debt-free.
Balance sheet — detailed (company disclosure)
Source: Q1 FY27 presentation, Historical Standalone Balance Sheet. Consolidated goodwill on Xmold is not disclosed in sources reviewed. Company-reported net debt/equity was −0.55x (FY24), −0.40x (FY25) and −0.30x (FY26). India Ratings computed net leverage including LC acceptances at −0.7x for FY25. The difference from the derived net cash above arises because the company presentation's net-debt definition is not stated. Investable surplus was INR 5,220 Mn (September 2025), INR 4,630 Mn (December 2025, CRISIL) and INR 8,740 Mn (June 2026).
Commentary.
Investment absorbed liquidity in FY24–FY26: Liquid assets fell from INR 10.9 bn to INR 7.2 bn as roughly INR 9 bn of capex (ABS, EPS II, SPC) and about INR 5.3 bn of dividends were funded internally.
Working capital swung: Inventories jumped 46% in FY25 ahead of ABS start-up and a rising SM market, then normalised in FY26. Receivables rose 28% in FY26 as Q4 sales surged.
Liquidity rebuilt quickly: Investable surplus recovered to INR 8.7 bn by June 2026, helped by Q1 FY27 cash generation.
Cash flow
Sources: Stock Analysis / Stockopedia (annual-report-based). Capex is derived as OCF minus FCF. Dividends declared are derived from split-adjusted DPS × 188.04 Mn shares; FY26 matches the company's outflow disclosure (interim INR 470.1 Mn plus final INR 1,504.3 Mn = INR 1,974 Mn, a 60.32% payout per AR FY26). Financing cash flow consists mainly of dividends and lease payments.
Commentary.
-
Cash conversion weakened through FY25–FY26. OCF/EBITDA fell to about 44% in FY26 as receivables rose and margins compressed.
-
Cumulative FY24–FY26 free cash flow (INR 2.5 bn) did not cover cumulative dividends (INR 5.5 bn). The gap was bridged by drawing down treasury. This was deliberate under a self-funding policy, but it cannot repeat indefinitely if the ₹900 cr capex programme overlaps with another spread downturn.
-
CRISIL expects net cash accrual of ₹300–400 cr per year against capex of ₹200–300 cr (base case) and liquid surplus maintained at ₹400–500 cr.
Return, leverage and efficiency ratios
Sources: AR FY26 ten-year table (ROANW, ROACE). Payable days for FY25 and FY26 are from BRSR; FY24 is derived. CRISIL reports interest coverage of 53.24x (FY24) and 40.16x (FY25) and adjusted debt/net worth of 0.06x including leases. The difference from the coverage figures above reflects CRISIL's operating-profit basis.
Commentary.
-
Returns have reset from super-normal (FY22 ROE 51%) to mid-teens. The decline was compounded in FY26 by a large, not-yet-productive asset base: ABS ran for only about four of the twelve months.
-
The cash conversion cycle widened from about 2 to about 17 days, a modest but notable deterioration that Ind-Ra flagged ("rising net working capital").
-
ROIC stays well above any reasonable cost of capital. The near-term lever is ABS utilisation on a roughly doubled gross block.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Relationship | Stake | Business | Source |
|---|---|---|---|---|
Supreme Petrochem Ltd | Listed parent | — | Styrenics manufacture and SM trading | AR FY26 |
Xmold Polymers Pvt Ltd (Tamil Nadu) | Subsidiary (first, from April 2025) | 80%; remaining 20% targeted by March 2027 | 15,000 TPA engineering polymer compounding plant at Gummidipoondi, near Chennai and Sri City; Tier-II supplier to auto and appliance OEMs | BRSR FY26; CRISIL |
TP Saturn Ltd (Tata Power Renewable SPV) | Captive power SPV; SPL holds a minority equity stake (size not disclosed; part of non-current investments) | — | 12.5 MW solar power supplied to Amdoshi under a Power Delivery Agreement | BRSR FY26; Q1 FY27 deck |
“—” = not publicly disclosed.
Business Lines
| Business line | FY2025 | FY2026 |
|---|---|---|
Manufactured products share of turnover (%) | 77.0 | 80.24 |
Traded goods (mainly SM) share of turnover (%) | 23.0 | 19.76 |
Manufactured products revenue (INR Mn, derived) | 46,380 | 42,835 |
Traded goods revenue (INR Mn, derived) | 13,854 | 10,549 |
Product Families
| Product family | Share of FY2025 revenue |
|---|---|
PS and EPS | 71% |
Specialty polymer compounds, masterbatches and XPS | 6% |
Traded goods (SM) | 23% |
ABS | 0% (commissioned September 2025) |
Operating Metrics (MT) and Segment Margins & Growth (%)
| Metric | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
Sales volume, manufactured products (MT) | 286,000 | 325,235 | 355,967 | 363,203 |
YoY volume growth (%) | 0 | 13.7 | 9.4 | 2.0 |
Results by Segment and Segment Margins & Growth (%)
| Metric | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|---|
Revenue from operations (INR Mn) | 13,865 | 11,002 | 12,647 | 15,870 | 16,927 |
Operating EBITDA (INR Mn) | 1,147 | 776 | 693 | 2,532 | 3,305 |
Operating EBITDA margin (%) | 8.27 | 7.05 | 5.48 | 15.95 | 19.53 |
PAT (INR Mn) | 809 | 482 | 302 | 1,680 | 2,363 |
Sales volume (MT) | 93,853 | 76,962 | 91,713 | 100,664 | 70,842 |
Products
| Product | Installed capacity | Location |
|---|---|---|
Polystyrene (GPPS + HIPS) | 300,000 TPA; rising to 380,000 TPA by March 2029 | Amdoshi |
Mass ABS | 70,000 TPA; Phase II to 140,000 TPA planned | Amdoshi |
EPS | 143,000 TPA (company total after EPS Phase II, including about 33,000 TPA at Manali) | Amdoshi + Manali |
Masterbatches and compounds | 50,000 TPA; expanding to 80,000 TPA | Amdoshi |
XPS boards | 72,000 m³; expanding to 122,000 m³ | Amdoshi |
Xmold compounding (subsidiary) | 15,000 TPA | Gummidipoondi, Tamil Nadu |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue from operations (INR Mn) | 50,323 | 52,872 | 52,533 | 60,234 | 53,384 |
Other income (INR Mn) | 305 | 589 | 681 | 732 | 433 |
Gross profit, aggregator basis (INR Mn) | 11,841 | 9,846 | 8,063 | 8,907 | 9,307 |
Operating EBITDA excl. other income (INR Mn) | 9,039 | 6,582 | 4,668 | 5,325 | 5,148 |
Total EBITDA incl. other income (INR Mn) | 9,344 | 7,171 | 5,349 | 6,058 | 5,581 |
Depreciation & amortisation (INR Mn) | 419 | 466 | 595 | 679 | 911 |
Operating income, Op. EBITDA minus D&A (INR Mn) | 8,620 | 6,116 | 4,073 | 4,646 | 4,237 |
Finance cost (INR Mn) | 48 | 36 | 72 | 124 | 141 |
Exceptional items (INR Mn) | 0 | 0 | 0 | 0 | -100 |
Profit before tax (INR Mn) | 8,878 | 6,669 | 4,682 | 5,254 | 4,429 |
Tax expense (INR Mn) | 2,245 | 1,688 | 1,217 | 1,349 | 1,156 |
Net profit / PAT (INR Mn) | 6,633 | 4,981 | 3,465 | 3,905 | 3,273 |
EPS basic = diluted (INR) | 35.27 | 26.49 | 18.43 | 20.77 | 17.41 |
Dividend per share as reported (INR) | 18.00 | 11.00 | 9.00 | 10.00 | 10.50 |
Dividend per share, split-adjusted to FV ₹2 (INR) | 9.00 | 9.00 | 9.00 | 10.00 | 10.50 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue growth YoY (%) | 58.0 | 5.1 | -0.6 | 14.7 | -11.4 |
Gross margin, aggregator basis (%) | 23.6 | 18.7 | 15.4 | 14.8 | 17.3 |
Operating EBITDA margin (%) | 17.96 | 12.45 | 8.89 | 8.84 | 9.64 |
Total EBITDA margin on revenue (%) | 18.57 | 13.56 | 10.18 | 10.06 | 10.45 |
Operating (EBIT) margin (%) | 17.13 | 11.57 | 7.75 | 7.71 | 7.94 |
PBT margin (%) | 17.64 | 12.61 | 8.91 | 8.72 | 8.30 |
Net margin (%) | 13.18 | 9.42 | 6.60 | 6.48 | 6.13 |
Effective tax rate (%) | 25.3 | 25.3 | 26.0 | 25.7 | 26.1 |
PAT growth YoY (%) | 38.9 | -24.9 | -30.4 | 12.7 | -16.2 |
Balance Sheet and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Shareholders' funds / net worth (INR Mn) | 15,156 | 18,439 | 20,191 | 22,313 | 23,702 |
Capital employed (INR Mn) | 15,500 | 18,793 | 20,565 | 22,711 | 24,274 |
Total assets (INR Mn; FY22–FY23 derived) | 22,431 | 26,921 | 30,648 | 34,481 | 34,667 |
Book value per share (INR) | 81 | 98 | 107 | 119 | 126 |
Total outside liabilities / net worth (x) | 0.48 | 0.46 | 0.50 | 0.53 | 0.44 |
Borrowings, short + long term (INR Mn) | 0 | 0 | 0 | 0 | 0 |
Balance Sheet
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Property, plant & equipment (INR Mn) | 6,575 | 6,907 | 13,581 |
Capital work-in-progress (INR Mn) | 2,326 | 5,808 | 741 |
Right-of-use assets (INR Mn) | 1,110 | 1,214 | 1,131 |
Intangible assets, standalone (INR Mn) | 3 | 9 | 16 |
Non-current investments incl. Xmold (INR Mn) | 0 | 54 | 374 |
Inventories (INR Mn) | 4,806 | 7,008 | 6,143 |
Trade receivables (INR Mn) | 3,950 | 3,932 | 5,038 |
Liquid mutual funds (INR Mn) | 5,718 | 4,300 | 2,868 |
Cash & cash equivalents (INR Mn) | 2,159 | 3,054 | 2,965 |
Other bank balances (INR Mn) | 3,045 | 1,564 | 1,363 |
Total liquid assets (INR Mn, derived) | 10,922 | 8,918 | 7,196 |
Trade payables (INR Mn) | 8,089 | 9,277 | 7,863 |
Lease liabilities, current + non-current (INR Mn) | 1,142 | 1,295 | 1,261 |
Net cash incl. leases as debt (INR Mn, derived) | 9,780 | 7,623 | 5,935 |
Current assets (INR Mn) | 20,027 | 20,213 | 18,662 |
Current liabilities (INR Mn) | 8,987 | 10,610 | 9,261 |
Working capital (INR Mn, derived) | 11,040 | 9,603 | 9,401 |
Total equity (INR Mn) | 20,191 | 22,313 | 23,702 |
Total assets (INR Mn) | 30,648 | 34,481 | 34,667 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (INR Mn) | 6,707 | 3,036 | 5,570 | 3,416 | 2,465 |
Capital expenditure (INR Mn, derived) | 1,630 | 2,053 | 3,131 | 3,763 | 2,092 |
Free cash flow (INR Mn) | 5,077 | 983 | 2,439 | -347 | 373 |
Investing cash flow (INR Mn) | -1,400 | -1,468 | -1,818 | -3,302 | -1,898 |
Financing cash flow (INR Mn) | -1,765 | -1,936 | -1,969 | -2,119 | -2,277 |
Dividends declared for the year (INR Mn, derived) | 1,692 | 1,692 | 1,692 | 1,880 | 1974 |
Share buybacks (INR Mn) | 0 | 0 | 0 | 0 | 0 |
Cash taxes paid (INR Mn) | 2,271 | 1,713 | 1,052 | 1,249 | 1,051 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE / ROANW, company (%) | 51.41 | 29.66 | 17.94 | 18.38 | 14.23 |
ROACE, PBIT/avg. capital employed, company (%) | 67.35 | 39.10 | 24.16 | 24.86 | 19.45 |
ROA, PAT/avg. total assets (%, derived) | 33.5 | 20.2 | 12.0 | 12.0 | 9.5 |
Interest coverage, PBIT/finance cost (x, derived) | 186 | 186 | 66 | 43 | 32 |
Asset turnover, revenue/avg. total assets (x, derived) | 2.54 | 2.14 | 1.83 | 1.85 | 1.54 |
Dividend payout, declared/PAT (%, derived) | 25.5 | 34.0 | 48.8 | 48.1 | 60.3 |
Financial Ratios (x) and Returns & Leverage Ratios (%)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Current ratio (x) | 2.23 | 1.91 | 2.02 |
Debt incl. leases / equity (x) | 0.06 | 0.06 | 0.05 |
Net debt / total EBITDA (x, negative = net cash) | -1.83 | -1.26 | -1.06 |
ROIC, NOPAT / (equity + leases − liquid assets) (%, derived) | 29.0 | 23.5 | 17.6 |
Inventory days on total expenses (days) | 36.6 | 46.6 | 46.5 |
Receivable days on revenue (days) | 27.4 | 23.8 | 34.4 |
Payable days (days) | 61.7 | 66.0 | 64.0 |
Cash conversion cycle (days) | 2.3 | 4.4 | 16.9 |
Region Overview
| Region | FY2026 |
|---|---|
India, domestic share of turnover (%) | 91.74 |
Exports share of turnover (%) | 8.26 |
India domestic revenue (INR Mn, derived) | 48,975 |
Export revenue (INR Mn, derived) | 4,409 |
Share Price History
| Date | Price (INR) | Market cap (INR Cr) | Source |
|---|---|---|---|
22 Apr 2025 | 626.85 | about 11,787 (derived) | IndMoney |
30 Sep 2025 | 832.35 | 15,652 | Q2 FY26 deck |
14 Jan 2026 | 543.85 | about 10,227 (derived) | Simply Wall St |
30 Jun 2026 | 714.65 | 13,438 | Q1 FY27 deck |
28 Aug 2026 | 692.95 | 13,282 | Anand Rathi |
18 Sep 2026 | 809.40 | 15,220 | Anand Rathi |
25 Sep 2026 | 879.90 | about 16,546 (derived) | Bajaj Finserv |
Valuation Multiples
| Multiple | Basis | Value |
|---|---|---|
P/E | TTM to June 2026 standalone EPS ₹25.67 (PAT INR 4,827 Mn) | 34.3x |
P/E | FY26 EPS ₹17.41 | 50.5x |
P/B | FY26 book value ₹126 | 7.0x |
EV/EBITDA | TTM total EBITDA INR 7,762 Mn; EV INR 156.7 bn (market cap less ₹874 cr surplus) | 20.2x |
EV/EBITDA | FY26 EBITDA INR 5,581 Mn; EV net of FY26 net cash | 28.6x |
EV/Sales | TTM revenue INR 56,446 Mn | 2.8x |
Dividend yield | ₹10.50 FY26 DPS | 1.19% |
Analyst Ratings & Targets
| Broker / source | Date | Rating | Target (INR) |
|---|---|---|---|
KRChoksey (Deven Choksey) | 30 Apr 2025 | — | 684 (18x FY27E EPS) |
KRChoksey | 29 Apr 2026 | — | 843 |
KRChoksey | 14 Jul 2026 | Accumulate | 813 |
Trendlyne consensus | 24 Jul 2026 | Hold | 791.5 |
AllInvestView consensus | 2026 | — | 805 |
Simply Wall St (3 analysts; most bullish) | 2026 | — | 875 |
Per-Share Data and Returns & Leverage Ratios (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
DPS split-adjusted (INR) | 9.00 | 9.00 | 9.00 | 10.00 | 10.50 |
Payout ratio (%) | 25.5 | 34.0 | 48.8 | 48.1 | 60.3 |
Credit Ratings
| Agency | Long-term | Short-term | Outlook | Date | Rated facilities |
|---|---|---|---|---|---|
CRISIL | AA- | A1+ | Stable (from Positive) | 27 Feb 2026 | ₹1,900 cr bank facilities |
India Ratings | IND AA- | IND A1+ | Stable (from Positive) | 17 Dec 2025 | INR 19,000 Mn bank facilities |
Moody's / S&P / Fitch | Not rated | — | — | — | — |
Analyst Conclusions
Management guidance.
-
No FY27 volume or margin guidance (Q1 FY27 call, July 2026). Management cited fluid demand, West Asia uncertainty for exports, and SM availability and shipping risks.
-
Management called the Q1 FY27 margin of about 19% an aberration.
-
Demand from non-OEM processors had returned by the end of Q1.
-
Committed capacity additions: SPC to 80 kt, XPS to 122k m³, PS to 380 kt by March 2029, ABS toward 140 kt, and the Karnal greenfield. All are internally funded within an expansion programme of about ₹900 cr.
Marketscreener-type projections exist for peers but not reliably for SPL. Price-target consensus is about ₹790–810 (Trendlyne; AllInvestView). The bullish Simply Wall St cohort assumes about 27% annual revenue growth over three years (an aggressive outlier).
Bull case.
-
Margin regime shift. Q4 FY26 (16.0%) and Q1 FY27 (19.5%) show earnings power of INR 3,000–3,500 Mn of quarterly EBITDA in a tight-delta world. With Gulf SM capacity impaired, deltas could stay above the CRISIL steady state of about 7%.
-
ABS and compounds re-rate the mix. Reaching 36 kt of ABS (FY27 target) and then 140 kt, monetised through Xmold and 80 kt of SPC, moves value-added products from about 6% toward 25–30% of manufactured revenue and lowers earnings volatility. Ind-Ra expects a higher through-cycle ABS margin.
-
Balance-sheet optionality. The ₹874 cr surplus with no debt allows the PS line, Karnal and ABS Phase II to proceed without dilution, while a payout of 50–60% supports yield.
Bear case.
-
Spread mean-reversion. Management itself calls Q1 an aberration. If deltas normalise as Gulf SM restarts, EBITDA could revert to FY24–FY26 levels (INR 5.3–6.1 bn per year). That would leave the stock at 26–30x EV/EBITDA, above the cycle average.
-
Execution and volume risk. Volume fell 24.5% in Q1 FY27; ABS has a history of delay and breakdown; and EPS competition is intensifying. FY26 volume growth was only 2% against guidance of about 10%.
-
Policy and import exposure. The 2026 duty suspension showed how quickly imports (about 87 kt of PS in FY26) can take share. Cash conversion has weakened (FCF of INR −347 Mn in FY25 and INR 373 Mn in FY26), while dividends exceed FCF.
Key catalysts and monitorables (next 12 months).
-
Q2 FY27 results (expected around 23 October 2026): durability of the delta, volume recovery and restart of exports.
-
ABS utilisation against the 36 kt FY27 target, and OEM approvals for ABS compounds.
-
Restoration of Gulf SM supply and Strait of Hormuz shipping.
-
Status of polymer import duties and anti-dumping.
-
Commissioning of SPC (80 kt) and the XPS expansion.
-
Purchase of Xmold's remaining 20% by March 2027.
-
Karnal environmental clearance and project sanction.
-
Interim dividend (October 2026) and capital allocation.
-
Further rating actions (CRISIL or Ind-Ra moving back to Positive).
-
Cooling-appliance season in Q4 FY27 and Q1 FY28.
Concluding analyst verdict.
Supreme Petrochem is a high-quality, conservatively financed franchise in a structurally cyclical business. Its standing as India's dominant styrenics producer is entrenched: more than 50% share, a rival's exit since 2020, the only domestic XPS plant and the first continuous mass-ABS line. Its balance sheet carries no debt and allows it to keep investing through downturns. Those are durable advantages, and they explain why ROACE stayed close to 20% even in the FY26 trough, when revenue fell 11% and the operating margin touched 5.5% in Q3.
The investment debate centres on two questions: whether the 2026 margin spike persists, and whether ABS changes the company's character. The evidence on the first is ambiguous. Q4 FY26 and Q1 FY27 margins were extraordinary, but management attributes them to a temporary global delta caused by the West Asia war, not to structural improvement. Q1 volume fell 24.5%. On the second question, the strategic direction is sound: ABS, compounds via Xmold, XPS and a northern greenfield. The record, however, is mixed so far. ABS ran late, broke down, and has yet to demonstrate commercial utilisation, while FY26 volume growth missed guidance badly.
At about ₹880, the stock trades on about 34x trailing and about 50x FY26 earnings, about 20x trailing EV/EBITDA and 7x book. It sits above every published sell-side target (₹684–875). That price capitalises much of the spike as durable. Our assessment is that the franchise merits a premium to Indian commodity chemicals, but the current valuation leaves little margin of safety if deltas normalise toward CRISIL's steady state of about 7%. We would characterise the shares as fairly to fully valued — Hold. The thesis would turn constructive on demonstrated ABS throughput of at least 3,000 t per month with OEM compound approvals, and on evidence that quarterly operating EBITDA can hold above INR 2,000 Mn without a geopolitical tailwind. It would turn negative on delta collapse combined with continued volume loss to imports.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure / background | Education | Age | FY2026 remuneration |
|---|---|---|---|---|---|
N. Gopal | Executive Director & Manager (statutory "Manager"; de facto chief executive and chief technologist) | Joined 1990 as Sr. VP (Projects & Operations); about 57 years in petrochemicals. Ex-ICI Petrochemicals (UK), IPCL, Reliance. Built the 66 kt PS plant and every expansion since; leads the Karnal project. Reappointed 20 April 2026 to 31 March 2029 | M.Sc., B.Tech (Chem. Eng.), Madras University; DIC (Advanced Chem. Eng.), Imperial College London | Above 70 (per AGM resolution) | ₹417.97 lakh (₹4.18 cr). Approved ceiling ₹525 lakh per year plus perquisites. Increment 6.7% in FY26 |
Rakesh Nayyar | Executive Director & CFO | — | — | — | Not individually disclosed in sources reviewed. Median KMP remuneration was ₹3.754 cr (BRSR); CFO increment 6.8% |
K. V. Mujumdar | Whole Time Director (Board member; responsible for BRSR/ESG) | DIN 08866096; Amdoshi plant-based leadership | — | — | Ratio to median employee 21.7:1 (about ₹1.6–1.7 cr implied; derived). Increment 7.6% |
D. N. Mishra | AVP & Company Secretary (FCS 5506) | Compliance officer | FCS | — | Not individually disclosed. Increment 11.3% |
“—” = not publicly disclosed.
Board of Directors
| Name | Category | Tenure / role | Age | Notes |
|---|---|---|---|---|
M. P. Taparia | Chairperson; Non-Executive, Non-Independent, Promoter | Director since 14 Dec 1989 | 88 | Managing Director, The Supreme Industries Ltd. Sitting fees ₹6 lakh in FY26. Holds 75,466 SPL shares |
Rajan B. Raheja | Non-Executive, Non-Independent, Promoter | Long-standing | — | Head of the Rajan Raheja group |
S. J. Taparia | Non-Executive, Non-Independent | Since 22 Nov 1993 | 80 | Executive Director, The Supreme Industries. Sitting fees ₹9 lakh. Holds 75,466 shares |
Akshay R. Raheja | Non-Executive, Non-Independent | — | — | Next generation of the Raheja family |
K. V. Mujumdar | Whole Time Director | Executive | — | See management table |
Rajeev M. Pandia | Independent | Appointed around FY24 (per AR FY24 references) | — | — |
Prof. (Dr.) Anup Kumar Ghosh | Independent | — | — | — |
Basavaraj N. Bankapur | Independent | Recent appointment | — | — |
Sanjay R. Chougule | Independent | — | — | — |
Rita A. Teaotia | Independent (woman) | — | — | Retired senior civil servant (former Union Commerce Secretary) |
Mona N. Desai | Independent (woman) | Recent appointment | — | — |
B. L. Taparia | Non-Executive (ceased) | Died 30 Jan 2026 | — | — |
“—” = not publicly disclosed.
Major Shareholders
| Holder category | Stake |
|---|---|
Promoters & promoter group | 64.24% |
Domestic institutions (mostly mutual funds) | 4.14% |
FPIs / FIIs | 3.80% |
Public and others | 27.82% |
Major Shareholders by Rank
| Rank | Holder | Stake | Source / date |
|---|---|---|---|
| 1 | The Supreme Industries Ltd (promoter) | 30.78% (57,872,800 shares) | Exchange SHP via Bajaj Finserv; CRISIL (Dec 2025) |
| 2 | R Raheja Investments Pvt Ltd (promoter) | 30.78% (57,872,800 shares) | Same |
| 3 | Investor Education & Protection Fund (IEPF) | 1.99% | Simply Wall St |
| 4 | HSBC Small Cap Fund (HSBC Mutual Fund) | 1.70% (3,198,370 shares) | Exchange SHP (Mar 2026) |
| 5 | Hathway Investments Pvt Ltd | 1.51% | Simply Wall St |
| 6 | The Vanguard Group | 1.11% | Simply Wall St |
| 7 | Dimensional Fund Advisors | 0.58% | Simply Wall St |
| 8 | ICICI Prudential AMC | 0.51% | Simply Wall St |
9–10 | Other institutions | — | — |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Type | Positioning versus SPL |
|---|---|---|---|
PS (GPPS/HIPS) | Styrenix Performance Materials Ltd (formerly INEOS Styrolution India) | Domestic listed | Second domestic styrenics producer; broader ABS and specialty portfolio |
PS | LG Polymers India (Visakhapatnam) | Domestic (idle) | Plant shut since the 2020 styrene leak; removed a major rival (CRISIL: second-largest player shut in FY21) |
PS imports | Producers in Thailand, South Korea, Taiwan, Iran and Singapore (CRISIL), e.g., INEOS Styrolution, Chi Mei, LG Chem, Formosa, TotalEnergies | Import competition | About 87 kt imported in FY26; surge in Q1 FY27 during the duty suspension; anti-dumping duties used historically |
EPS | EPACK group (EPS beads) and other new domestic entrants | Domestic | Capacity additions in FY25 (KRChoksey); price competition in a fragmented moulder market |
EPS imports | Asian EPS bead producers | Import | Price-setting at the margin |
ABS | Styrenix Performance Materials | Domestic listed | Incumbent largest Indian ABS producer (emulsion process) with ASA, PC/ABS and SAN |
ABS | Bhansali Engineering Polymers Ltd | Domestic listed | — |
ABS imports | LG Chem, Chi Mei, Lotte Chemical, Formosa and others | Import | Bulk of Indian ABS demand historically imported |
Compounds and masterbatches | Kingfa Science & Technology (India), Plastiblends India, Avient and others | Domestic / MNC | Fragmented market; SPL's edge is captive base polymers and OEM relationships |
XPS | Imported XPS brands; PIR/PUF and mineral-wool alternatives | Import / substitutes | SPL is the only domestic XPS producer |
Peer Comparison FY2026
| Metric | Supreme Petrochem (standalone) | Styrenix Performance Materials (consolidated) |
|---|---|---|
Revenue (INR Mn) | 53,384 | 34,380 |
Revenue growth YoY (%) | -11.4 | 15.3 |
EBITDA margin (%) | 10.45 (total) / 9.64 (operating) | 10.4 (company); 9.98 (Stock Analysis) |
PAT (INR Mn) | 3,273 | 1,828 |
Net margin (%) | 6.13 | 5.3 |
R&D intensity (%) | 0 (statutory) | — |
Net debt | Net cash | Net debt (interest cost INR 194.5 Mn) |
“—” = not publicly disclosed.
Recent Developments
The Q1 FY27 earnings-call date is reported as 29 July 2026 in the scheduling intimation; one aggregator cites 27 July.



